PCR & Real-time PCR Molecular Diagnostics Market by Type and Application- Global Industry Analysis & Forecast to 2027

Published On : January 2021 Pages : 158 Category: Biotechnology Report Code : HC0215367

PCR & Real-time PCR Molecular Diagnostics Market By Type (Traditional PCR, Real-time PCR, and Digital PCR); Application (Infectious Diseases Testing, Oncology Testing, Genetic Testing, and Others)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The PCR & Real-time PCR Molecular Diagnostics Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.PCR & Real-time PCR Molecular Diagnosticstechnique is used to identify whether a target genetic sequence of DNA or RNA is present in a sample.PCR & Real-time PCR allows monitoring of the amplification process in real-time, and can even be used to quantify, or count, the amount of DNA/RNA present.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global PCR & Real-time PCR Molecular Diagnostics Marketand estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • Hologic, Inc.
  • GRIFOLS

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         PCR & Real-time PCR Molecular Diagnostics Market , By Product Type, Estimates and Forecast, 2017-2027 ($Million)

o    Traditional PCR

o    Real-time PCR

o    Digital PCR

·         PCR & Real-time PCR Molecular Diagnostics Market , ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Infectious Diseases Testing

o    Oncology Testing

o    Genetic Testing

o    Others

·         PCR & Real-time PCR Molecular Diagnostics Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Abbott Laboratories

o    Bio-Rad Laboratories, Inc.

o    bioMérieux SA

o    Danaher Corporation

o    Thermo Fisher Scientific, Inc.

o    Becton, Dickinson and Company

o    F. Hoffmann-La Roche Ltd

o    QIAGEN N.V.

o    Hologic, Inc.

o    GRIFOLS

·         PCR & Real-time PCR Molecular Diagnostics Market , By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America PCR & Real-time PCR Molecular Diagnostics Market , By Country

o    U.S. PCR & Real-time PCR Molecular Diagnostics Market

o    Canada PCR & Real-time PCR Molecular Diagnostics Market

o    Mexico PCR & Real-time PCR Molecular Diagnostics Market

o    Europe

§  Europe PCR & Real-time PCR Molecular Diagnostics Market , By Country

o    UK PCR & Real-time PCR Molecular Diagnostics Market

o    Germany PCR & Real-time PCR Molecular Diagnostics Market

o    France PCR & Real-time PCR Molecular Diagnostics Market

o    Russia PCR & Real-time PCR Molecular Diagnostics Market

o    Italy PCR & Real-time PCR Molecular Diagnostics Market

o    Rest of Europe PCR & Real-time PCR Molecular Diagnostics Market

o    Asia-Pacific

§  Asia-Pacific PCR & Real-time PCR Molecular Diagnostics Market , By Country

o    China PCR & Real-time PCR Molecular Diagnostics Market

o    Japan PCR & Real-time PCR Molecular Diagnostics Market

o    South Korea PCR & Real-time PCR Molecular Diagnostics Market

o    India PCR & Real-time PCR Molecular Diagnostics Market

o    Southeast Asia PCR & Real-time PCR Molecular Diagnostics Market

o    Rest of Asia-Pacific PCR & Real-time PCR Molecular Diagnostics Market

o    South America

§  South America PCR & Real-time PCR Molecular Diagnostics Market

o    Brazil PCR & Real-time PCR Molecular Diagnostics Market

o    Argentina PCR & Real-time PCR Molecular Diagnostics Market

o    Columbia PCR & Real-time PCR Molecular Diagnostics Market

o    Rest of South America PCR & Real-time PCR Molecular Diagnostics Market

o    Middle East and Africa

§  Middle East and Africa PCR & Real-time PCR Molecular Diagnostics Market

o    Saudi Arabia PCR & Real-time PCR Molecular Diagnostics Market

o    UAE PCR & Real-time PCR Molecular Diagnostics Market

o    Egypt PCR & Real-time PCR Molecular Diagnostics Market

o    Nigeria PCR & Real-time PCR Molecular Diagnostics Market

o    South Africa PCR & Real-time PCR Molecular Diagnostics Market

o    TurkeyPCR & Real-time PCR Molecular Diagnostics Market

o    Rest of MEA PCR & Real-time PCR Molecular Diagnostics Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       PCR And Real-time PCR Molecular Diagnostics  Market, By Product Type

5.1.     Introduction

5.2.     Global PCR And Real-time PCR Molecular Diagnostics  Revenue and Market Share by Product Type (2017-2021)

5.2.1.  Global PCR And Real-time PCR Molecular Diagnostics  Revenue and Revenue Share by Product Type (2017-2021)

5.3.     Traditional PCR

5.3.1.  Global Traditional PCR Revenue and Growth Rate (2017-2021)

5.4.     Real-time PCR

5.4.1.  Global Real-time PCR Revenue and Growth Rate (2017-2021)

5.5.     Digital PCR

5.5.1.  Global Digital PCR Revenue and Growth Rate (2017-2021)

6.       PCR And Real-time PCR Molecular Diagnostics  Market, By Applications

6.1.     Introduction

6.2.     Global PCR And Real-time PCR Molecular Diagnostics  Revenue and Market Share by Applications (2017-2021)

6.2.1.  Global PCR And Real-time PCR Molecular Diagnostics  Revenue and Revenue Share by Applications (2017-2021)

6.3.     Infectious Diseases Testing

6.3.1.  Global Infectious Diseases Testing Revenue and Growth Rate (2017-2021)

6.4.     Oncology Testing

6.4.1.  Global Oncology Testing Revenue and Growth Rate (2017-2021)

6.5.     Genetic Testing

6.5.1.  Global Genetic Testing Revenue and Growth Rate (2017-2021)

6.6.     Others

6.6.1.  Global Others Revenue and Growth Rate (2017-2021)

7.       PCR And Real-time PCR Molecular Diagnostics  Market, By Region

7.1.     Introduction

7.2.     Global PCR And Real-time PCR Molecular Diagnostics  Revenue and Market Share by Regions

7.2.1.  Global PCR And Real-time PCR Molecular Diagnostics  Revenue by Regions (2017-2021)

7.3.     North America PCR And Real-time PCR Molecular Diagnostics  by Countries

7.3.1.  North America PCR And Real-time PCR Molecular Diagnostics  Revenue and Growth Rate (2017-2021)

7.3.2.  North America PCR And Real-time PCR Molecular Diagnostics  Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe PCR And Real-time PCR Molecular Diagnostics  by Countries

7.4.1.  Europe PCR And Real-time PCR Molecular Diagnostics  Revenue and Growth Rate (2017-2021)

7.4.2.  Europe PCR And Real-time PCR Molecular Diagnostics  Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific PCR And Real-time PCR Molecular Diagnostics  by Countries

7.5.1.  Asia-Pacific PCR And Real-time PCR Molecular Diagnostics  Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific PCR And Real-time PCR Molecular Diagnostics  Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America PCR And Real-time PCR Molecular Diagnostics  by Countries

7.6.1.  South America PCR And Real-time PCR Molecular Diagnostics  Revenue and Growth Rate (2017-2021)

7.6.2.  South America PCR And Real-time PCR Molecular Diagnostics  Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa PCR And Real-time PCR Molecular Diagnostics  by Countries

7.7.1.  Middle East and Africa PCR And Real-time PCR Molecular Diagnostics  Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa PCR And Real-time PCR Molecular Diagnostics  Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     Abbott Laboratories

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Bio-Rad Laboratories, Inc.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     bioMérieux SA

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Danaher Corporation

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Thermo Fisher Scientific, Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Becton, Dickinson and Company

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     F. Hoffmann-La Roche Ltd

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     QIAGEN N.V.

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Hologic, Inc.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. GRIFOLS

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.1.     Global PCR And Real-time PCR Molecular Diagnostics  Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     PCR And Real-time PCR Molecular Diagnostics  Market Forecast by Regions (2022-2027)

9.2.1.  North America PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.1.1.  United States PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.1.2.  Canada PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.1.3.  Mexico PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.2.  Europe PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.2.1.  Germany PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.2.2.  France PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.2.3.  UK PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.2.4.  Russia PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.2.5.  Italy PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.3.  Asia-Pacific PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.3.1.  China PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.3.2.  Japan PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.3.3.  Korea PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.3.4.  India PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.4.  South America PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.4.1.  Brazil PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.4.2.  Argentina PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.4.3.  Columbia PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.4.4.  Rest of South America PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.5.  Middle East and Africa PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.5.3.  Egypt PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.5.4.  Nigeria PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.5.5.  South Africa PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.5.6.  Turkey PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa PCR And Real-time PCR Molecular Diagnostics  Market Forecast (2022-2027)

9.3.     PCR And Real-time PCR Molecular Diagnostics  Market Forecast by Product Type (2022-2027)

9.3.1.  PCR And Real-time PCR Molecular Diagnostics  Forecast by Product Type (2022-2027)

9.3.2.  PCR And Real-time PCR Molecular Diagnostics  Market Share Forecast by Product Type (2022-2027)

9.4.     PCR And Real-time PCR Molecular Diagnostics  Market Forecast by Applications (2022-2027)

9.4.1.  PCR And Real-time PCR Molecular Diagnostics  Forecast by Applications (2022-2027)

9.4.2.  PCR And Real-time PCR Molecular Diagnostics  Market Share Forecast by Applications (2022-2027)


List of Tables

List of Tables and Figures:

Figure United States PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure France PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure China PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure India PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) and Growth Rate (2017-2027)
Table Global PCR And Real-time PCR Molecular Diagnostics Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Traditional PCR Revenue and Growth Rate (2017-2019)
Figure Global Real-time PCR Revenue and Growth Rate (2017-2019)
Figure Global Digital PCR Revenue and Growth Rate (2017-2019)
Table Global PCR And Real-time PCR Molecular Diagnostics Revenue and Revenue Share by Applications (2017-2019)
Figure Global Infectious Diseases Testing Revenue and Growth Rate (2017-2019)
Figure Global Oncology Testing Revenue and Growth Rate (2017-2019)
Figure Global Genetic Testing Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global PCR And Real-time PCR Molecular Diagnostics Revenue by Regions (2017-2019)
Figure North America PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure North America PCR And Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2019)
Figure North America PCR And Real-time PCR Molecular Diagnostics by Countries (2017-2019)
Figure North America PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure United States PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure United States PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Canada PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Mexico PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Europe PCR And Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2019)
Figure Europe PCR And Real-time PCR Molecular Diagnostics by Countries (2017-2019)
Figure Europe PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure Germany PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Germany PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure France PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure UK PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Russia PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Italy PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Rest of Europe PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Asia-Pacific PCR And Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific PCR And Real-time PCR Molecular Diagnostics by Countries (2017-2019)
Figure Asia-Pacific PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure China PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure China PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Japan PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Korea PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure India PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Southeast Asia PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Rest of Asia-Pacific PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure South America PCR And Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2019)
Figure South America PCR And Real-time PCR Molecular Diagnostics by Countries (2017-2019)
Figure South America PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure Brazil PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Brazil PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Argentina PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Columbia PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Rest of South America PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Middle East and Africa PCR And Real-time PCR Molecular Diagnostics Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa PCR And Real-time PCR Molecular Diagnostics by Countries (2017-2019)
Figure Middle East and Africa PCR And Real-time PCR Molecular Diagnostics Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Saudi Arabia PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure United Arab Emirates PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Egypt PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Nigeria PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure South Africa PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Turkey PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa PCR And Real-time PCR Molecular Diagnostics Growth Rate (2017-2019)
Figure Rest of Middle East and Africa PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2017-2019)
Table Abbott Laboratories PCR And Real-time PCR Molecular Diagnostics Financial Overview
Table Bio-Rad Laboratories, Inc. PCR And Real-time PCR Molecular Diagnostics Financial Overview
Table bioMérieux SA PCR And Real-time PCR Molecular Diagnostics Financial Overview
Table Danaher Corporation PCR And Real-time PCR Molecular Diagnostics Financial Overview
Table Thermo Fisher Scientific, Inc. PCR And Real-time PCR Molecular Diagnostics Financial Overview
Table Becton, Dickinson and Company PCR And Real-time PCR Molecular Diagnostics Financial Overview
Table F. Hoffmann-La Roche Ltd PCR And Real-time PCR Molecular Diagnostics Financial Overview
Table QIAGEN N.V. PCR And Real-time PCR Molecular Diagnostics Financial Overview
Table Hologic, Inc. PCR And Real-time PCR Molecular Diagnostics Financial Overview
Table GRIFOLS PCR And Real-time PCR Molecular Diagnostics Financial Overview
Figure Global PCR And Real-time PCR Molecular Diagnostics Revenue (Millions USD) and Growth Rate (2019-2027)
Table PCR And Real-time PCR Molecular Diagnostics Market Forecast by Regions (2019-2027)
Figure North America PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure United States PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Canada PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Mexico PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Europe PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Germany PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure France PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure UK PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Russia PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Italy PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Rest of Europe PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Asia-Pacific PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure China PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Japan PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Korea PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure India PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Southeast Asia PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Rest of Asia-Pacific PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure South America PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Brazil PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Argentina PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Columbia PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Rest of South America PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Middle East and Africa PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Saudi Arabia PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure United Arab Emirates PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Egypt PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Nigeria PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure South Africa PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Turkey PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Rest of Middle East and Africa PCR And Real-time PCR Molecular Diagnostics Market Forecast (2019-2027)
Figure Global PCR And Real-time PCR Molecular Diagnostics Forecast by Product Type (2019-2027)
Figure Global PCR And Real-time PCR Molecular Diagnostics Market Share Forecast by Product Type (2019-2027)
Figure Global PCR And Real-time PCR Molecular Diagnostics Forecast by Product Type (2019-2027)
Figure Global PCR And Real-time PCR Molecular Diagnostics Forecast by Applications (2019-2027)
Figure Global PCR And Real-time PCR Molecular Diagnostics Market Share Forecast by Applications (2019-2027)
Figure Global PCR And Real-time PCR Molecular Diagnostics Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*